Seaport-based Satio is radically improving the workflow of healthcare to allow it to decentralize while providing improved outcomes and broader, more equitable access. The two areas of focus are drug and vaccine delivery and on-board in vitro diagnostics. The origin of Satio and KKR Sapphiros traces to founder Namal Nawana, former CEO of Alere and of Smith & Nephew, who continues to pursue the passion he developed for decentralizing care of the highest quality prior to selling Alere to Abbott. https://satiopatch.com/news/

About Croda’s Pharma business – www.crodapharma.com Croda’s Pharma business is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations, committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid, delivery platforms.

Millstone Medical is a leading CDMO providing end-to-end solutions for combination device & drug packaging, assembly, testing and distribution. Founded in 2000 and headquartered in Massachusetts, Millstone Medical is your single source solution for clinical trials of combination products and speed to market. Our ISO 13485 dedicated class 7 clean rooms, innovative technology and skilled teams will guide your device from development to market. Our certified laboratories provide product, packaging and environmental testing to our biopharmaceutical customers 60% faster than industry norms. To learn more, please visit www.millstonemedical.com.

Ligandal delivers molecules precisely where they need to go. Using flexibly manufacturable, organ- and tissue-specific peptide ligands, their rapid and predictive, payload- and target-agnostic platform enables personalized, precision, and preventative medicine through delivery of nucleic acids, proteins, and molecular materials. Powered by LigandAI® and Predictive Interactomics®. For more information, visit https://api.ligandal.com/

ARx custom develops and manufactures transdermal patches and oral/transmucosal thin film delivery systems for unique drug delivery and patient needs. Our drug delivery technologies expand delivery possibilities for active pharmaceutical ingredients with tailored drug delivery profiles that meet the therapeutic needs of the patient with rapid onset or controlled release, all while enhancing compliance, bioavailability, and avoiding adverse events associated with the 1st pass metabolism. We partner to improve drug delivery at any stage in drug development, from product concept & feasibility assessment through commercial production.

Q2BI is a biometrical and clinical science contract research organization (CRO) for the life science industry product/drug development and regulatory submissions. Founded in 2009, Q2BI has a broad range of expertise-based services in the areas of Electronic Data Capture (EDC), Clinical Data Management (CDM), Medical Services (Medical Writing, Medical Monitoring, Medical Coding), Statistical Programming, Biostatistical science, Safety Monitoring including IDMC/DSMB, Pharmacokinetics / Pharmacodynamics (PK/PD), Data Science including data visualization/analytics and System Validation Consulting. Q2BI is a pioneer in adopting CDISC and supported the world’s first FDA Project ORBIS.

AdhereTech is revolutionizing clinical trial adherence with its innovative Aidia System. Unlike traditional methods such as pill counting, journals, or video capture, our patented smart cap technology provides unparalleled accuracy in medication adherence tracking while minimizing patient burden. We address the critical need for increasing medication adherence, helping biotech and pharma companies maximize effect size and demonstrate efficacy. Our solution overcomes limitations of current offerings and doesn’t require additional stability testing. By partnering with AdhereTech, clinical operations teams ensure regulatory compliance, optimize drug accountability, and can avoid significant financial and operational consequences of failed trials due to non-adherence. For more information, please visit https://adheretech.com/

EMIT Imaging offers Cryo-Fluorescence Tomography (CFT) instrumentation and services, enabling a transformative 3D approach to analyze whole-animal therapeutic distribution and protein expression. Our imaging platform, XerraTM, provides high resolution and sensitivity imaging for improved visualization of multiplexed whole-body distribution and delivery, co-localization of drug with targets, and on/off target tissue identification. For more information, contact https://emitimaging.com/.

Stratacuity is a trusted boutique biotech staffing agency, founded in 2001, with a mission to drive groundbreaking scientific advancements. Our experienced scientific recruiters have a strong history of successfully placing exceptional talent at prominent life sciences companies in Boston and beyond. From assisting with critical initial hires through executive search, we are committed to supporting your success. Proven Scientific Placement

For more information, please visit https://www.stratacuity.com/

Image Analysis Group is a leading imaging Clinical Research Organization, combining medical expertise, a global team and the DYNAMIKA platform with embedded AI capabilities for data management and central review. For nearly 20 years, IAG supports pharma companies in developing novel drugs, using imaging to assess safety and efficacy. For more information, visit https://www.ia-grp.com/about-us/

At Artcraft Health, we believe that information is not the same as education. More successful outcomes—for all clinical trial stakeholders—start with an approach of Educated Consent™ . With our expertise in health education, we partner with you to develop and execute materials and solutions that go beyond just informing to engaging and educating. It’s a difference that can help overcome clinical trials challenges and make a tremendous impact on your study data. To learn more, please visit https://www.artcrafthealth.com/educated-consent

Expand your design possibilities with Celanese engineered materials and support from in-house technical experts. Our high-performance polymers and thermoplastics unlock opportunities for improving patient care with cutting-edge medical and pharmaceutical solutions. Applications include drug delivery, long-acting controlled release delivery, medical devices, orthopedics, advanced surgical instruments, connected devices and more. To learn more, visit http://www.celanese.com/